• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Heartbeam, Inc. - Common Stock (NQ:BEAT)

    1.950 -0.040 (-2.01%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 28,864
    Open 1.960
    Bid (Size) 1.820 (4)
    Ask (Size) 2.090 (2)
    Prev. Close 1.990
    Today's Range 1.823 - 2.040
    52wk Range 1.450 - 3.480
    Shares Outstanding 34,260,799
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia Partner to Advance Remote ECG Monitoring
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation
    From HeartBeam, Inc.
    Via Business Wire

    Performance

    YTD
    -17.0%
    -17.0%
    1 Month
    N/A
    N/A
    3 Month
    -9.3%
    -9.3%
    6 Month
    -20.1%
    -20.1%
    1 Year
    -4.9%
    -4.9%

    More News

    Read More
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Reports Q4 and Full-Year 2024 Financial Results, Highlights FDA Clearance and Commercial Progress
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    HeartBeam Reports Fourth Quarter and Full Year 2024 Results
    From HeartBeam, Inc.
    Via Business Wire
    Earnings Scheduled For March 13, 2025
    Via Benzinga
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at Upcoming Investor and Industry Conferences
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Report Q4 and Full-Year 2024 Results on March 13
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Underwriter Exercises Option, Increasing Gross Proceeds to $11.5M
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Prices $10 Million Public Offering at $1.70 Per Share
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Submits FDA Application for 12-Lead ECG Synthesis Software
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at JP Morgan 2025 Annual Healthcare Conference
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
    From HeartBeam, Inc.
    Via Business Wire
    HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Positive Data for Groundbreaking Technology at AHA Conference
    Via Investor Brand Network
    HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Technology with FDA Submissions and Key Leadership Appointments
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    HeartBeam Reports Third Quarter 2024 Results
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 Earnings Call with Key Regulatory and Initiative Updates
    Via Investor Brand Network
    Topics Earnings Intellectual Property
    Exposures Financial Intellectual Property
    HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
    From HeartBeam, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Heartbeam, Inc. - Common Stock publicly traded?
    Yes, Heartbeam, Inc. - Common Stock is publicly traded.
    What exchange does Heartbeam, Inc. - Common Stock trade on?
    Heartbeam, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Heartbeam, Inc. - Common Stock?
    The ticker symbol for Heartbeam, Inc. - Common Stock is BEAT on the Nasdaq Stock Market
    What is the current price of Heartbeam, Inc. - Common Stock?
    The current price of Heartbeam, Inc. - Common Stock is 1.950
    When was Heartbeam, Inc. - Common Stock last traded?
    The last trade of Heartbeam, Inc. - Common Stock was at 04/28/25 04:00 PM ET
    What is the market capitalization of Heartbeam, Inc. - Common Stock?
    The market capitalization of Heartbeam, Inc. - Common Stock is 66.81M
    How many shares of Heartbeam, Inc. - Common Stock are outstanding?
    Heartbeam, Inc. - Common Stock has 67M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.